Saba Discloses 7.58% Destiny Tech100 Stake, Citing NAV Discount and Possible Liquidation

Boaz Weinstein's Saba Capital Management disclosed 3,611,594 DXYZ shares on a Schedule 13D filed November 20, 2026, bought for about $96.2 million, 90% of them in the sixty days before filing and 1,102,098 of them on November 19 at $24.67, a 35.6% discount to the fund's last reported NAV of $38.32 at September 30. Item 4 says the shares are undervalued and identifies what Saba may raise with the board: the discount, the fund's closed-end form, the timing of any liquidation, buy-backs, tenders, director nominations and a change of investment manager, 'which may be the Reporting Person'. Separately, J. Goldman & Co, the 5.57% holder in August, reported 1.06% as of September 30.

By , Head of Research· AltStreet Research· SEC filings (CIK 0001843974)
Headline card for Saba Discloses 7.58% Destiny Tech100 Stake, Citing NAV Discount and Possible Liquidation

Key facts

8
  1. Schedule 13D filed November 20, 2026 (accession 0001062993-26-006212; date of event November 18, 2026) by Saba Capital Management, L.P., Saba Capital Management GP, LLC and Boaz R. Weinstein, reporting 3,611,594 common shares of Destiny Tech100 Inc. (NYSE: DXYZ), 7.58% of the 47,657,338 shares outstanding at October 9, 2026 per the fund's October 23 proxy statement. Voting and dispositive power are shared; the funds and accounts Saba advises have the right to the dividends and sale proceeds.
  2. Item 3: 'A total of approximately $96,227,048 was paid to acquire the Common Shares reported herein', from investor subscription proceeds, appreciation and margin borrowings; $26.64 a share on average.
  3. Schedule A lists 36 open-market purchases in the sixty days before filing, all buys, totaling 3,270,242 shares or 90.5% of the reported position; the largest is 1,102,098 shares at $24.67 on November 19, 2026, the day before the filing.
  4. Item 4: the shares were acquired 'because they believe that the Common Shares are undervalued and represent an attractive investment opportunity'. The filers identify matters they may raise with management, the board and other shareholders, including 'trading of the Common Shares at a discount to the Issuer's net asset value and strategic plans and matters relating to the open or closed end nature of the Issuer and timing of any potential liquidation of the Issuer'; they may make shareholder proposals, nominate directors and solicit proxies; and they 'may seek to influence the Issuer to engage in share buy-backs, tenders, and liquidations and/or to change its governance, investment strategy and/or investment manager (which may be the Reporting Person)'. These are options the filing identifies, not demands delivered; the filers also reserve the right to sell or hedge.
  5. Item 6: no contracts or understandings with any person on the issuer's securities other than the joint filing agreement; the filers 'have not entered into any agreement with any third party to act together'.
  6. Reference price: DXYZ's last reported NAV is $38.32 a share at September 30, 2026 (prospectus supplement of November 16, 2026, accession 0001575872-26-000797); the November 19 purchase price of $24.67 is a 35.6% discount to it. The latest reported NAV is dated September 30 and does not establish the fund's NAV on Saba's November purchase dates. Separately, the fund reported about $112.0 million of new investments in October 2026.
  7. J. Goldman & Co LP, J. Goldman Capital Management, Inc. and Jay G. Goldman filed Schedule 13G/A No. 1 on November 16, 2026 (accession 0000902664-26-004549) reporting 507,318 shares, 1.06%, as of September 30, 2026, from 5.57% on the August 2026 Schedule 13G.
  8. The fund's board approved a discretionary program to repurchase shares below NAV in August 2026 (N-CSRS, accession 0001213900-26-095201); the filings AltStreet has read describe no completed repurchases. AltStreet located no response from the fund to the 13D in the sources searched.

Saba Capital Management, L.P., the closed-end fund investor run by Boaz Weinstein, filed a Schedule 13D on Destiny Tech100 Inc. on November 20, 2026, reporting 3,611,594 shares, 7.58% of the fund's 47,657,338 shares outstanding. The filing states that approximately $96,227,048 was paid for the position, $26.64 a share on average, and its schedule of recent trades shows that 90.5% of it was bought in the sixty days before filing, including 1,102,098 shares at $24.67 on November 19, the day before the filing. Against the fund's last reported net asset value, $38.32 a share at September 30, 2026, that price is a 35.6% discount.

A Schedule 13D, unlike the 13G that passive holders file, requires the filer to state its purpose. Saba's Item 4 says the shares are undervalued and identifies what it may take up with the board and other shareholders: the shares' trading 'at a discount to the Issuer's net asset value', 'matters relating to the open or closed end nature of the Issuer and timing of any potential liquidation of the Issuer', board appointments, shareholder proposals, proxy solicitation, and influencing the fund 'to engage in share buy-backs, tenders, and liquidations and/or to change its governance, investment strategy and/or investment manager (which may be the Reporting Person)'. Those are options the filing identifies, not demands delivered; a 13D records a purpose, and this one makes no proposal.

The position and how it was built

The 13D is a first filing, with a date of event of November 18, 2026, the day the position crossed 5%. Schedule A lists 36 open-market purchases between September 23 and November 19, all buys, for 3,270,242 shares, which leaves about 341,000 shares bought before the sixty-day window. The November 19 purchase of 1,102,098 shares at $24.67 was the largest and accounts for 30.5% of the position. The filing notes that margin borrowings were among the sources of funds. The three filers, Saba Capital, its general partner and Mr. Weinstein, report shared voting and dispositive power and state that they have no agreement with any third party to act together; Item 6 lists no other contracts on the shares.

The discount Saba names, and what the fund has filed about it

DXYZ's price history is the subject of the AltStreet review: a closing price of $99.79 against a $5.15 NAV in April 2024, an issuance-driven rise in NAV through 2025 and 2026, and a share price that moved to a discount in the first quarter of 2026. The fund reports NAV quarterly; the September 30, 2026 figure of $38.32 came in a November 16 prospectus supplement that also stated no shares were sold under the at-the-market program in the quarter. The latest reported NAV is dated September 30 and does not establish the fund's NAV on Saba's November purchase dates, so the 35.6% figure compares a November price with a September value. Separately, the fund reported about $112.0 million of new investments in October 2026; what those positions are worth today will appear in the December 31 reports.

The fund's own filed response to the discount is a discretionary program, approved by the board in August 2026, to repurchase shares below NAV; the filings AltStreet has read describe no completed repurchases. The 13D's Item 4 lists buy-backs and tenders among the actions Saba may raise, along with 'liquidations' and a change of investment manager that could be Saba itself. The filing also reserves the right to buy more, sell, or hedge, and states that the filers may change their purpose at any time.

A second ownership change on the file

In a separate development, J. Goldman & Co LP, which the AltStreet review had recorded as the only institutional holder above 5% on an August 2026 Schedule 13G at 5.57%, filed an amendment on November 16 reporting 507,318 shares, 1.06%, as of September 30, 2026. That figure is six weeks older than Saba's November purchases and describes a different holder's decision; the two filings are not a hand-off. The fund's CEO letter in the June 2026 semiannual report said that recent filings showed 'a number of institutions starting (or expanding) positions'; Saba's is the first filing on the fund's EDGAR record from a holder that states an intention to engage the board.

See the opportunity. Understand the risk.

Get the latest on Destiny Tech100

Follow the latest on Destiny Tech100, discover new deals, and keep an eye on the risks. Get market news, platform updates, and independent research that helps you see beyond the pitch, delivered to your inbox.

New dealsMarket newsPlatform updates

Make your next move an informed one

Get the latest on Destiny Tech100 and the wider alternative markets. Join free.

Independent intelligence from AltStreet. No hype. No sponsor spin.

What this report does not cover

The purpose language is Saba's statement of what it may do, not of what it will do. The $26.64 average cost, the 90.5% and 30.5% shares of the position and the 35.6% discount are AltStreet arithmetic from the filed $96,227,048, the Schedule A share counts and the filed $38.32 NAV. AltStreet has not asked Destiny Tech100, DX Advisors or Saba Capital, and nothing here is a view on the value of DXYZ shares.

Sources

  1. Schedule 13D, Saba Capital Management, L.P. et al. on Destiny Tech100 Inc., filed November 20, 2026 (accession 0001062993-26-006212) — SEC EDGAR
  2. Exhibit 2, Schedule A of transactions in the past sixty days — SEC EDGAR
  3. Schedule 13G/A No. 1, J. Goldman & Co LP on Destiny Tech100 Inc., filed November 16, 2026 (accession 0000902664-26-004549) — SEC EDGAR
  4. Prospectus Supplement No. 2, Destiny Tech100 Inc., November 16, 2026 (accession 0001575872-26-000797): NAV $38.32 at September 30, 2026 — SEC EDGAR
  5. Destiny Tech100 (DXYZ) review — AltStreet Research